Lev1g 0007 01
Chemical structure diagram of Levetiracetam, showing its molecular formula and arrangement of atoms.*
Levetiracetam In Sodium Chloride Injection
Product Images NDC 14789-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam In Sodium Chloride (NDC 14789-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lev1g 0007 02
A bar chart comparing patient response percentages among three groups: placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The placebo group shows 7.4%, the 1000 mg/day group shows 37.1%, and the 3000 mg/day group 39.6%, with statistical significance noted for the Levetiracetam groups versus placebo.*
Lev1g 0007 03
Bar graph comparing the percentage of patients for Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day groups. The y-axis represents percentage of patients from 0% to 45%, showing increasing rates from Placebo (6.3%) to Levetiracetam 1000 mg/day (20.8%) and Levetiracetam 2000 mg/day (35.2%). Asterisks indicate statistical significance versus placebo.*
Lev1g 0007 04
A bar graph comparing the percentage of patients between two groups: a placebo group (104 patients) with 14.4% response, and a Levetiracetam 3000 mg/day group (180 patients) with 39.4% response. The graph notes statistical significance of the Levetiracetam group versus placebo.*
Lev1g 0007 05
A bar graph comparing the percentage of patients responding to placebo versus levetiracetam treatment. The placebo group shows 45.2% of patients, while the levetiracetam group shows a higher response rate of 72.2%, with an asterisk indicating a statistically significant difference between groups.*
Lev1g 0007 06
Lev1g 0007 07
Packaging label for Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL) intravenous infusion by Nexus Pharmaceuticals LLC. The label indicates 10 single-use bags per package, with dosage instructions to infuse over 15 minutes. The label includes cautions, storage recommendations, and specifies that the product is Rx only.*
Lev1g 0007 08
Label for Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL) intravenous injection in a 100 mL single-dose container. Manufactured for Nexus Pharmaceuticals LLC. The label includes usage instructions, storage recommendations, lot and expiration placeholders, and a barcode.*
Lev1g 0007 09
Packaging label for Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL) intravenous infusion. The label indicates a prescription drug for intravenous infusion only, supplied in 10 single-use bags. It is manufactured by Nexus Pharmaceuticals LLC with NDC 14789-220-10. The label includes dosage and storage instructions and a barcode.*
Lev1g 0007 10
Label for Levetiracetam in 0.75% Sodium Chloride Injection 1000 mg/100 mL (10 mg/mL) intravenous injection by Nexus Pharmaceuticals. The 100 mL single-dose container label includes administration instructions, storage recommendations, and manufacturing details. It is labeled for intravenous infusion only and single-use dual port bag packaging.*
Lev1g 0007 11
Packaging label for Levetiracetam in 0.54% Sodium Chloride Injection, 1500 mg/100 mL (15 mg/mL) strength, intravenous infusion. The label indicates the product is Rx only, distributed in 10 single-use bags, and manufactured by Nexus Pharmaceuticals LLC. Instructions for infusion over 15 minutes and storage are included, along with the NDC 14789-330-15.*
Lev1g 0007 12
Label for Levetiracetam in 0.54% Sodium Chloride Injection, 1500 mg per 100 mL (15 mg/mL) intravenous infusion. The injection is supplied in a 100 mL single-dose container by Nexus Pharmaceuticals LLC. The label includes administration instructions, storage recommendations, and barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
